BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33189001)

  • 21. Do demographics and tumour-related factors affect nodal yield at neck dissection? A retrospective cohort study.
    Lim RS; Evans L; George AP; de Alwis N; Stimpson P; Merriel S; Giddings CE; Billah B; Smith JA; Safdar A; Sigston E
    J Laryngol Otol; 2017 Jan; 131(S1):S36-S40. PubMed ID: 27786150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.
    Pramana J; Van den Brekel MW; van Velthuysen ML; Wessels LF; Nuyten DS; Hofland I; Atsma D; Pimentel N; Hoebers FJ; Rasch CR; Begg AC
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1544-52. PubMed ID: 17931799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes.
    Park JC; Durbeck J; Clark JR; Faden DL
    Oral Oncol; 2020 Dec; 111():105024. PubMed ID: 33065374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
    Dasgupta A; Fatima K; DiCenzo D; Bhardwaj D; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
    Cancer Med; 2021 Apr; 10(8):2579-2589. PubMed ID: 33314716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer.
    Sher DJ; Pham NL; Shah JL; Sen N; Williams KA; Subramaniam RM; Moore W; Chorley R; Ahn C; Khan SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):932-940. PubMed ID: 33127491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of [
    Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
    Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiomics nomogram of MR: a prediction of cervical lymph node metastasis in laryngeal cancer].
    Jia CL; Cao Y; Song Q; Zhang WB; Li JJ; Wu XX; Yu PY; Mou YK; Mao N; Song XC
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1154-1161. PubMed ID: 33342131
    [No Abstract]   [Full Text] [Related]  

  • 28. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial.
    Elbers JBW; Al-Mamgani A; Tesseslaar MET; van den Brekel MWM; Lange CAH; van der Wal JE; Verheij M; Zuur CL; de Boer JP
    Radiother Oncol; 2020 Jan; 142():79-84. PubMed ID: 31563412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of cervical lymph node metastases in head and neck cancer with ultrasonic measurement of lymph node volume.
    Nishio N; Fujimoto Y; Hiramatsu M; Maruo T; Tsuzuki H; Mukoyama N; Yokoi S; Wada A; Kaneko Furukawa M; Furukawa M; Sone M
    Auris Nasus Larynx; 2019 Dec; 46(6):889-895. PubMed ID: 30857763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.
    Men K; Geng H; Zhong H; Fan Y; Lin A; Xiao Y
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):440-447. PubMed ID: 31201897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.
    de Veij Mestdagh PD; Schreuder WH; Vogel WV; Donswijk ML; van Werkhoven E; van der Wal JE; Dirven R; Karakullukcu B; Sonke JJ; van den Brekel MWM; Marijnen CAM; Al-Mamgani A
    BMC Cancer; 2019 Nov; 19(1):1110. PubMed ID: 31727019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT Texture Analysis of Cervical Lymph Nodes on Contrast-Enhanced [
    Kuno H; Garg N; Qureshi MM; Chapman MN; Li B; Meibom SK; Truong MT; Takumi K; Sakai O
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):543-550. PubMed ID: 30792253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomic Model Predicts Lymph Node Response to Induction Chemotherapy in Locally Advanced Head and Neck Cancer.
    Zhang MH; Cao D; Ginat DT
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33806029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
    Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Scoring System for Prediction of Cervical Lymph Node Metastasis in Patients with Head and Neck Squamous Cell Carcinoma.
    Chung MS; Choi YJ; Kim SO; Lee YS; Hong JY; Lee JH; Baek JH
    AJNR Am J Neuroradiol; 2019 Jun; 40(6):1049-1054. PubMed ID: 31072971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
    Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
    Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
    Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
    EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.